Positions en cours
| Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 17/05/23 | MEDIAN TECHNOLOGIES | Achat | 4 000 E | 4.30 | 5.30 | 22.81% | 912 |
|
0 |
| 03/05/23 | OSE IMMUNOTHERAPEUTICS | Achat | 2 000 E | 3.82 | 3.70 | -3.54% | -71 |
|
0 |
| 11/01/23 | INTEGRAGEN | Achat | 2 000 E | 1.37 | 0.22 | -84.10% | -1 682 |
|
1 |
| 11/01/23 | INTEGRAGEN | Achat | 2 000 E | 1.37 | 0.22 | -84.10% | -1 682 |
|
1 |
| 11/01/23 | INTEGRAGEN | Achat | 2 000 E | 1.37 | 0.22 | -84.10% | -1 682 |
|
1 |
| 04/10/22 | ADVICENNE | Achat | 2 000 E | 4.00 | 1.10 | -72.71% | -1 454 |
|
2 |
| 04/10/22 | ADVICENNE | Achat | 2 000 E | 4.00 | 1.10 | -72.71% | -1 454 |
|
2 |
| 04/10/22 | OSE IMMUNOTHERAPEUTICS | Achat | 1 000 E | 4.90 | 3.70 | -24.84% | -248 |
|
3 |
| 05/09/22 | OSE IMMUNOTHERAPEUTICS | Achat | 2 000 E | 7.68 | 3.70 | -52.12% | -1 042 |
|
3 |
| 03/08/22 | OSE IMMUNOTHERAPEUTICS | Achat | 2 000 E | 6.50 | 3.70 | -43.39% | -868 |
|
5 |
| 11/08/21 | ADVICENNE | Achat | 2 000 E | 7.31 | 1.10 | -85.15% | -1 703 |
|
6 |
| 11/08/21 | ADVICENNE | Achat | 2 000 E | 7.31 | 1.10 | -85.15% | -1 703 |
|
7 |
| 11/08/21 | ADVICENNE | Achat | 2 000 E | 7.31 | 1.10 | -85.15% | -1 703 |
|
6 |
| 08/09/20 | INNATE PHARMA | Achat | 1 600 E | 3.80 | 1.55 | -59.25% | -948 |
|
10 |
| 08/09/20 | INNATE PHARMA | Achat | 1 500 E | 4.05 | 1.55 | -61.77% | -927 |
|
10 |
| 08/09/20 | INNATE PHARMA | Achat | 1 600 E | 4.20 | 1.55 | -63.14% | -1 010 |
|
16 |
| 30/07/20 | INNATE PHARMA | Achat | 750 E | 5.04 | 1.55 | -69.30% | -520 |
|
9 |
| 29/06/20 | INNATE PHARMA | Achat | 2 000 E | 5.70 | 1.55 | -72.86% | -1 457 |
|
9 |
| 14/05/20 | OSE IMMUNOTHERAPEUTICS | Achat | 1 000 E | 6.16 | 3.70 | -40.10% | -401 |
|
9 |
| 14/05/20 | OSE IMMUNOTHERAPEUTICS | Achat | 1 000 E | 6.16 | 3.70 | -40.10% | -401 |
|
7 |
| 19/07/19 | INNATE PHARMA | Achat | 1 200 E | 5.72 | 1.55 | -72.96% | -876 |
|
10 |
| 25/06/19 | INNATE PHARMA | Achat | 700 E | 5.65 | 1.55 | -72.62% | -508 |
|
7 |
| 18/06/19 | INNATE PHARMA | Achat | 650 E | 5.94 | 1.55 | -73.96% | -481 |
|
11 |
| 28/05/19 | INNATE PHARMA | Achat | 950 E | 5.82 | 1.55 | -73.43% | -698 |
|
11 |
| 24/05/19 | OSE IMMUNOTHERAPEUTICS | Achat | 1 500 E | 3.76 | 3.70 | -1.79% | -27 |
|
9 |
| 24/05/19 | INNATE PHARMA | Achat | 1 500 E | 5.85 | 1.55 | -73.56% | -1 103 |
|
9 |
| Enregistrements 1 à 26 sur 26 | |||||||||
Positions soldées
| Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
| 29/08/24 | OSE IMMUNOTHERAPEUTICS | Achat | 800 E | 3.65 | 7.92 | 116.67% | 933 | |
11 |
| 29/08/24 | OSE IMMUNOTHERAPEUTICS | Achat | 800 E | 3.40 | 7.92 | 132.61% | 1 061 | |
11 |
| 05/01/23 | MAUNA KEA TECHNOLOGIES | Achat | 1 200 E | 1.11 | 0.42 | -62.30% | -748 | |
10 |
| 05/01/23 | MAUNA KEA TECHNOLOGIES | Achat | 1 200 E | 1.11 | 0.42 | -62.30% | -748 | |
8 |
| 05/01/23 | MAUNA KEA TECHNOLOGIES | Achat | 1 500 E | 1.11 | 0.42 | -62.30% | -935 | |
8 |
| 05/01/23 | MAUNA KEA TECHNOLOGIES | Achat | 1 000 E | 1.11 | 0.42 | -62.30% | -623 | |
8 |
| 05/01/23 | THERADIAG | Achat | 750 E | 2.62 | 2.28 | -13.16% | -99 | |
8 |
| 05/01/23 | THERADIAG | Achat | 500 E | 2.41 | 2.28 | -5.59% | -28 | |
11 |
| 05/01/23 | THERADIAG | Achat | 700 E | 1.94 | 2.28 | 17.31% | 121 | |
9 |
| 05/01/23 | THERADIAG | Achat | 1 100 E | 1.85 | 2.28 | 22.80% | 251 | |
7 |
| 05/01/23 | THERADIAG | Achat | 800 E | 1.85 | 2.28 | 22.80% | 182 | |
7 |
| 02/01/23 | POXEL | Achat | 2 000 E | 1.57 | 0.99 | -37.27% | -745 | |
2 |
| 02/01/23 | POXEL | Achat | 2 000 E | 1.59 | 0.99 | -38.06% | -761 | |
2 |
| 02/01/23 | GENSIGHT BIOLOGICS SA | Achat | 1 000 E | 3.89 | 3.43 | -12.01% | -120 | |
10 |
| 02/01/23 | GENSIGHT BIOLOGICS SA | Achat | 1 000 E | 3.87 | 3.43 | -11.56% | -116 | |
9 |
| 02/01/23 | GENSIGHT BIOLOGICS SA | Achat | 1 000 E | 3.87 | 3.43 | -11.56% | -116 | |
8 |
| 05/09/22 | INNATE PHARMA | Achat | 1 500 E | 2.78 | 2.60 | -6.86% | -103 | |
7 |
| 05/09/22 | INNATE PHARMA | Achat | 2 000 E | 2.70 | 2.60 | -4.10% | -82 | |
4 |
| 19/01/22 | ACTIA GROUP | Achat | 750 E | 2.25 | 4.57 | 102.81% | 771 | |
7 |
| 19/01/22 | ACTIA GROUP | Achat | 750 E | 2.25 | 4.57 | 102.81% | 771 | |
7 |
| 19/01/22 | ACTIA GROUP | Achat | 750 E | 2.20 | 4.57 | 107.42% | 806 | |
7 |
| 19/01/22 | ACTIA GROUP | Achat | 750 E | 2.20 | 4.57 | 107.42% | 806 | |
11 |
| 19/01/22 | ACTIA GROUP | Achat | 1 000 E | 2.31 | 4.57 | 97.54% | 975 | |
10 |
| 19/11/21 | THERADIAG
|
DS | 0 E | 0.00 | 0.08 | 0.00% | 24 | |
3 |
| 19/11/21 | THERADIAG
|
DS | 0 E | 0.00 | 0.08 | 0.00% | 17 | |
3 |
| 19/11/21 | THERADIAG
|
DS | 0 E | 0.00 | 0.08 | 0.00% | 30 | |
1 |
| 19/11/21 | THERADIAG
|
DS | 0 E | 0.00 | 0.08 | 0.00% | 49 | |
4 |
| 19/11/21 | THERADIAG
|
DS | 0 E | 0.00 | 0.08 | 0.00% | 36 | |
3 |
| 25/10/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 750 E | 6.15 | 3.22 | -47.79% | -358 | |
10 |
| 25/10/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 500 E | 5.90 | 3.22 | -45.58% | -228 | |
8 |
| 25/10/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 500 E | 5.84 | 3.22 | -45.02% | -225 | |
6 |
| 25/10/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 500 E | 5.84 | 3.20 | -45.36% | -227 | |
6 |
| 21/09/21 | L'OREAL | Achat | 10 000 E | 398.75 | 372.70 | -7.88% | -788 | |
4 |
| 21/09/21 | L'OREAL | Achat | 10 000 E | 398.85 | 372.70 | -7.90% | -790 | |
4 |
| 12/08/21 | SOCIETE GENERALE | Achat | 10 000 E | 27.54 | 27.52 | -0.50% | -50 | |
4 |
| 12/08/21 | SOCIETE GENERALE | Achat | 10 000 E | 27.54 | 27.52 | -0.50% | -50 | |
2 |
| 11/08/21 | TRANSGENE | Achat | 700 E | 1.78 | 2.27 | 27.30% | 191 | |
4 |
| 11/08/21 | TRANSGENE | Achat | 850 E | 1.78 | 2.27 | 27.30% | 232 | |
4 |
| 11/08/21 | TRANSGENE | Achat | 1 000 E | 1.79 | 2.27 | 26.59% | 266 | |
15 |
| 11/08/21 | REWORLD MEDIA | Achat | 1 000 E | 2.89 | 4.07 | 40.59% | 406 | |
7 |
| 11/08/21 | REWORLD MEDIA | Achat | 1 000 E | 2.89 | 4.07 | 40.59% | 406 | |
5 |
| 11/08/21 | REWORLD MEDIA | Achat | 1 000 E | 2.81 | 4.07 | 44.60% | 446 | |
4 |
| 11/08/21 | REWORLD MEDIA | Achat | 800 E | 2.81 | 4.07 | 44.60% | 357 | |
7 |
| 11/08/21 | REWORLD MEDIA | Achat | 800 E | 2.81 | 4.07 | 44.60% | 357 | |
4 |
| 11/08/21 | REWORLD MEDIA | Achat | 800 E | 2.81 | 4.07 | 44.60% | 357 | |
5 |
| 11/01/21 | NEXTEDIA | Achat | 800 E | 0.65 | 1.50 | 130.44% | 1 044 | |
9 |
| 11/01/21 | NEXTEDIA | Achat | 1 000 E | 0.59 | 1.50 | 153.88% | 1 539 | |
8 |
| 21/12/20 | VALNEVA SE | Achat | 500 E | 3.21 | 8.37 | 160.39% | 802 | |
6 |
| 13/11/20 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.15 | 0.00% | 50 | |
4 |
| 13/11/20 | ACTIA GROUP
|
DIV | 0 E | 0.00 | 0.15 | 0.00% | 50 | |
4 |
| Enregistrements 1 à 50 sur 170 | |||||||||



